Signature Genomic Labs to Solely Offer Array CGH Services on Roche NimbleGen Platform
November 10, 2009
Signature Genomic Labs to Solely Offer Array CGH Services on Roche NimbleGen Platform
As part of the deal, announced last week, Roche NimbleGen will make, market, and sell worldwide CGH arrays designed by Signature for cytogenetics research, while Signature will provide and support software analysis tools for Roche array customers.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Cytogeneticists Say Platform Choice a Question of Personal Preference, Circumstance
August 21, 2012 / BioArray News - Germany's ImaGenes, Partners to Use $4M Gov't Grant in Array-Based Nutrigenomics Study
July 14, 2009 / BioArray News - Amid Market Exits and Acquisitions, 2012 Saw Arrays Gain Ground in Prenatal, DTC Markets
January 2, 2013 / BioArray News - Affymetrix to Start Clinical Trials for CytoScan HD in March, Plans FDA Submission by Midyear
January 17, 2012 / BioArray News - Roche NimbleGen to Expand CGH Array Menu, Plans Additional High-Density Chips
March 29, 2011 / BioArray News